Scarica il documento in formato pdf (1196 KB) - ANCE
Scarica il documento in formato pdf (1196 KB) - ANCE
Scarica il documento in formato pdf (1196 KB) - ANCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
scolari si suddividano equamente tra i due gruppi<br />
selezionati dalla randomizzazione;<br />
5. la valutazione della mortalità specifica cardiovascolare<br />
viene pur sempre esplorata come endpo<strong>in</strong>t<br />
secondario; <strong>in</strong> questo caso le discrepanze con l’endpo<strong>in</strong>t<br />
primario vanno valutate con prudenza.<br />
Il problema comunque è comune ad altre sperimentazioni<br />
ed è oggetto di discussioni.<br />
BIBLIOGRAFIA<br />
1. Cazeau S, Leclercq C, Lavergne T et al. Multisite stimulation<br />
<strong>in</strong> cardiomyopathies (MUSTIC). Effect of multisite<br />
biventricular pac<strong>in</strong>g <strong>in</strong> patients with heart fa<strong>il</strong>ure and<br />
<strong>in</strong>traventricular conduction delay. N Engl J Med 2001;<br />
344: 873-80.<br />
2. Abraham WT, Fisher WG, Smith AL et al. Multisite Insync<br />
Randomized Cl<strong>in</strong>ical Evaluation (MIRACLE). Double-bl<strong>in</strong>d,<br />
randomized controlled trial of cardiac resynchronization<br />
<strong>in</strong> chronic heart fa<strong>il</strong>ure. N Engl J Med 2002; 346: 1845-53.<br />
3. Hasan A, Abraham WT. Cardiac resynchronization treatment<br />
of heart fa<strong>il</strong>ure. Annu Rev Med 2007; 58: 63-74.<br />
4. Lozano I, Bocchiardo M, Achtelik M et al. Impact of biventricular<br />
pac<strong>in</strong>g on mortality <strong>in</strong> a randomized crossover<br />
study of patients with heart fa<strong>il</strong>ure and ventricular arrhythmias<br />
(VENTAK CHF/CONTAK CD). Pac<strong>in</strong>g Cl<strong>in</strong><br />
Electrophysiol 2000; 23: 1711-2.<br />
5. Molhoek SG, Bax JJ, Van Erven L et al. QRS duration and<br />
shorten<strong>in</strong>g to predict cl<strong>in</strong>ical response to cardiac resynchronization<br />
therapy <strong>in</strong> patients with end-stage heart fa<strong>il</strong>ure.<br />
Pac<strong>in</strong>g Cl<strong>in</strong> Electrophysiol 2004; 27: 308-13.<br />
6. Gerber TC, Nishimura RA, Holmes DR et al. Left ventricular<br />
and biventricular pac<strong>in</strong>g <strong>in</strong> congestive heart fa<strong>il</strong>ure.<br />
Mayo Cl<strong>in</strong> Proc 2001; 76: 803-12.<br />
7. Rajagopalan N, Suffoletto MS, Tanabe M et al. Right ventricular<br />
function follow<strong>in</strong>g cardiac resynchronization therapy.<br />
Am J Cardiol 2007; 100: 1434-6.<br />
8. Fruhwald FM, Fahrleitner-Pammer A, Berger R et al. Early<br />
and susta<strong>in</strong>ed effects of cardiac resynchronization therapy<br />
on N-term<strong>in</strong>al pro-B-type natriuretic peptide <strong>in</strong> patients<br />
with moderate to severe heart fa<strong>il</strong>ure and cardiac dyssynchrony.<br />
Eur Heart J 2007; 28: 1592-7.<br />
9. Wasserman K, Sun XG, Hansen JE. Effect of biventricular<br />
pac<strong>in</strong>g on the exercise pathophysiology of heart fa<strong>il</strong>ure.<br />
Chest 2007; 132: 250-61.<br />
10. Molhoek SG, Bax JJ, Bleeker GB et al. Long-term follow-up<br />
of cardiac resynchronization therapy <strong>in</strong> patients with end-<br />
25<br />
E. Enia La ris<strong>in</strong>cronizzazione cardiaca. III° I benefici<br />
stage heart fa<strong>il</strong>ure. J Cardiovasc Electrophysiol 2005; 16:<br />
701-7.<br />
11. Jansen AHM, van Dantzig J, Bracke F et al. Improvement<br />
<strong>in</strong> diastolic function and left ventricular f<strong>il</strong>l<strong>in</strong>g pressure<br />
<strong>in</strong>duced by cardiac resynchronization therapy. Am Heart J<br />
2007; 153: 843-9.<br />
12. St John Sutton M, Plappert T, H<strong>il</strong>pisch KE et al Susta<strong>in</strong>ed<br />
reverse left ventricular structural remodel<strong>in</strong>g with cardiac<br />
resynchronization at one year is a function of etiology.<br />
Circulation 2006; 113: 266-72.<br />
13. Yu CM, Bleeker GB, Fung JW et al. Left ventricular reverse<br />
remodel<strong>in</strong>g but not cl<strong>in</strong>ical improvement predicts longterm<br />
survival after cardiac resynchronization therapy.<br />
Circulation 2005; 112: 1580-6.<br />
14. Vanderheyden M, Mullens W, Delrue L et al. Myocardial<br />
gene expression <strong>in</strong> heart fa<strong>il</strong>ure patients treated with cardiac<br />
resynchronization therapy. JACC 2008; 51: 129-36.<br />
15. Bristow MR, Saxon LA, Boehmer J et al. Comparison of<br />
medical therapy, pac<strong>in</strong>g and defibr<strong>il</strong>lation <strong>in</strong> heart fa<strong>il</strong>ure<br />
(COMPANION). Cardiac resynchronisation therapy with<br />
or without an implantable defibr<strong>il</strong>lator <strong>in</strong> advanced chronic<br />
heart fa<strong>il</strong>ure. N Engl J Med 2004; 350: 2140-50.<br />
16. Cleland J, Daubert JC, Erdmann E et al. The effect of cardiac<br />
resynchronization on morbidity and mortality <strong>in</strong><br />
heart fa<strong>il</strong>ure (CARE-HF). N Engl J Med 2005; 352: 1539-<br />
49.<br />
17. Cleland JG, Daubert JC, Erdmann E et al. Longer term<br />
effects of cardiac resynchronization therapy on mortality<br />
<strong>in</strong> heart fa<strong>il</strong>ure. CARE-HF trial extension phase. Eur Heart J<br />
2006; 27: 1928-32.<br />
18. Mc Alister FA, Ezekowitz J, Hooton N et al. Cardiac resynchronization<br />
therapy for patients with left ventricular<br />
systolic dysfunction. A systematic review. JAMA 2007;<br />
297: 2502-14.<br />
19. Auricchio A, Metra M, Gaspar<strong>in</strong>i M et al. Long-term survival<br />
of patients with heart fa<strong>il</strong>ure and ventricular conduction<br />
delay treated with cardiac resynchronization therapy.<br />
Am J Cardiol, 2007; 99: 232-8.<br />
20. National Institute for Health and Cl<strong>in</strong>ical Excellence<br />
(NICE). NICE technology appraisal guidance 120. Cardiac<br />
resynchronisation therapy for the treatment of heart fa<strong>il</strong>ure.<br />
May 2007. Http://guidance.nice.org.uk.<br />
21. Rivero-Ayerza M, Theuns D, Garcia-Garcia HM et al.<br />
Effects of cardiac resynchronization therapy on overall<br />
mortality and mode of death. A meta-analysis of randomized<br />
controlled trials. Eur Heart J 2006; 27: 2682-8.<br />
22. Friedewald VE, Boehmer JP, Kowal RC et al. The editor’s<br />
roundtable. Cardiac resynchronization therapy. Am J<br />
Cardiol 2007; 1145-52.<br />
23. Lubsen J, Kirwan BA. Comb<strong>in</strong>ed endpo<strong>in</strong>ts: can we use<br />
them? Stat Med 2002; 21: 2959-70.